New Digital Platform To Help Women Detect Breast Cancer Earlier
Around 135,000 women across New Zealand who are eligible but not currently enrolled for breast cancer screening will benefit from the successful national rollout of a new digital platform, Health Minister Simeon Brown says.
'The launch of Te Puna across the country is a major step forward for delivering faster and smarter screening services,' Mr Brown says.
'Te Puna replaces an outdated legacy system with a modern, streamlined platform that makes it easier for women to enrol, book, and manage their breast screening appointments – helping more women get screened earlier.'
The new system, which began rolling out in February, is now live nationwide. It introduces a more proactive approach to screening, with women now automatically identified when they become eligible and invited to book a mammogram – shifting from an opt-in to an opt-out model.
'This change will significantly boost participation and help close the gap for the 135,000 eligible women who aren't currently getting screened.
'Early detection through regular mammograms is critical. Women diagnosed through screening are about 34 per cent less likely to die from breast cancer. This new system will make it easier for more women to get the checks they need, when they need them.'
Te Puna significantly enhances data tracking, accuracy, and reporting – helping providers identify and reach women who have never screened or don't screen regularly. It also improves convenience for patients, allowing women to book or change appointments using a secure personalised link or QR code sent via text, email, or letter.
'This Government is focused on lifting screening rates to save more lives and improve treatment outcomes. Te Puna will play a vital role in achieving that.
'We're also delivering on our commitment to extend breast screening to women aged 70 to 74, with rollout of the expansion beginning later this year.
'Every woman deserves the chance for early detection and timely treatment. Te Puna is about putting the right tools in place to deliver better care, faster – and ultimately, to save lives,' Mr Brown says.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
19 hours ago
- Scoop
Faster Access To Neurosurgery For South Islanders
Minister of Health Fewer South Island patients are waiting for life-changing neurosurgery, with more people getting the specialist treatment they need faster, Health Minister Simeon Brown says. 'Neurosurgery is vital for treating serious brain and spinal conditions that can dramatically affect lives if left too long,' Mr Brown says. 'Putting patients first means making sure every Kiwi can access timely, quality healthcare when they need it, and that is exactly what our focus is on for the South Island.' Between November 2023 and March 2025, the number of people waiting for neurosurgery in the South Island has fallen by 22 per cent, from 98 to 76. The number waiting longer than four months for surgery has dropped by 45 per cent, from 31 to 17. 'This is great progress, and it is making a real difference to people's lives. 'Whether it is a parent needing urgent brain surgery to be there for their children, or a worker recovering from spinal treatment and returning to their community, this is about delivering for patients.' This improvement follows a difficult period when the neurosurgery waitlist in the South Island rose by 92 per cent between 2020 and 2023, putting extra pressure on patients and health services. 'These results show our focus on reducing waitlists is delivering. We are investing in surgical teams, boosting capacity, and working closely with hospitals to ensure more New Zealanders get the specialist care they need sooner. 'This progress also reflects the hard work and dedication of our frontline health professionals, whose commitment to patient care is critical to achieving these results. 'We're also focused on ensuring that the longest waiting patients get the care they need. That's why it's encouraging to see not only the total waitlist coming down, but the number of people waiting more than four months reducing at a faster rate of 45 per cent. 'This is all part of our plan to provide timely, quality healthcare for every New Zealander. If you need specialist treatment like neurosurgery, you should be able to get it when you need it.' Reducing wait times for elective procedures is a key priority for this Government. Our health target is clear – by 2030, 95 per cent of patients will be treated within four months. 'Patients are still waiting too long, and there is still more work to do, but this latest data shows we are heading in the right direction,' Mr Brown says.
Otago Daily Times
a day ago
- Otago Daily Times
Govt cuts tender for work on hospital foundations
The government has cancelled a tender for work on the foundations of Dunedin's new hospital due to "substantive" design changes. However, Health New Zealand Te Whatu Ora (HNZ) says the project remains on track despite the cancellation of the tender and the design changes were only to the foundations, not the overall inpatient building. A document sent to contractors by HNZ on Monday, and obtained by the Otago Daily Times , said due to "substantive changes in design of the substructure work" a request for tender had been cancelled. Health Minister Simeon Brown issued the tender request for substructure works on the foundation of the main structure in May; it including the installation of the lower slab, concreting and plinths for base isolators. Mr Brown said yesterday contractual decisions were a matter for Crown manager Evan Davies, who was appointed in June. "I am advised that the project remains on track with the timeline previously outlined," Mr Brown said. On-site activity had "ramped up" — work to cap the 324 foundation piles had begun and substructure work was expected to start early next year, to be completed by July 2026. Mr Brown had previously said base isolators, used to minimise earthquake damage, would be installed in July and steel structure construction would begin by August 2026. Dunedin MP Rachel Brooking feared the cancellation would mean further delays to the project and residents were "over it". "The government needs to get on with it and build the hospital Dunedin was promised," she said. A Health NZ spokesperson said the design changes related to "technical details" of the substructure. It did not relate to any design change to the facility's health services and the building's form had not changed, they said. HNZ did not answer the ODT 's questions on why the changes were not envisioned when the tender was released or who would complete the substructure work. The inpatient building was "on track" and pile capping work would be complete by the end of the year, the spokesperson said. They thanked the companies which had submitted a tender for the substructure works. Representatives from potential contracting firms, including Naylor Love, Breen Construction, Ceres — which holds the contract for some of the building's substructure — and Leighs Construction, were spotted at a tender debrief at the inpatient building site in May. Firm representatives were either unable to be reached or declined to comment yesterday. The cancellation of the tender comes after a whirlwind of change this year in who leads the project. In June, two former hospital build bosses rejoined the project — Mr Davies, who resigned as chairman of the build's governance board in 2023, returned as Crown manager and it is understood former programme director Tony Lloyd, who was let go from the role last November, is back working on the project. In July, the ODT reported HNZ and Australian construction giant CPB had signed a "letter of intent", meaning the firm should be awarded the contract to deliver the building. A letter of intent can also mean a firm can work on a project prior to the contract being signed — it was highly likely Ceres would finish its part of the contract then hand over to CPB for completion of the main build. At the time, sources said they did not anticipate a third main contractor to lead any part of the substructure's build.
RNZ News
2 days ago
- RNZ News
Advertising unapproved medicines not legal, despite government claim
In a statement, Minister for Regulation David Seymour said the restriction on advertising new medicines at medical conferences "is being removed". Photo: RNZ / Mark Papalii Despite a government announcement suggesting it has lifted the ban on advertising unapproved medicines, it remains a criminal offence, warn legal experts. In a joint media release with Health Minister Simeon Brown, Minister for Regulation David Seymour welcomed "confirmation" of two major medical conferences in New Zealand next year, following the rule change to allow advertising of unapproved medicines at trade shows. The Ministry for Regulation had found the "overly cautious approach" was out of step with other recognised jurisdictions, and the government "acted fast to fix it", Seymour said. However, leading intellectual property lawyer Paul Johns - head of litigation for Pearce IP - cautioned the law had not yet changed. "If I were the organiser of these conferences and had seen those media releases, I would be making sure that my sponsors were aware that in fact the law has not changed and any medicines they want to advertise ought to be approved, because the consequences are criminal - there are fines and even imprisonment. "I don't think you would get that far, but they're there." Parliament was currently considering some amendments to the Medicines Act (to enable faster approval of drugs and widen powers for nurse prescribers) but there was nothing to do with advertising, he said. "It's still possible that the government could submit an amendment paper and put this advertising thing in there as well, but they haven't. So they appear to have a policy but they've done nothing about it in terms of legislation." The "great irony" was that under the Therapeutic Products Act - which was repealed by the current administration - the government could have simply introduced new regulations allowing such advertising, Johns noted. "But now they need to amend the Medicines Act." Others have pointed out that medical conferences were planned years in advance, so the new policy could not have been the deciding factor for next year's bookings. In a written response to RNZ's questions, Minister Seymour said the restriction on advertising new medicines at medical conferences "is being removed". "Ending New Zealand's prohibition on advertising medicines at medical conferences and trade shows has sent a message that New Zealand is open for business. That's exactly what medical conference organisers needed to hear, with two already confirmed for 2026." Medicines New Zealand chief executive Dr Graeme Jarvis said New Zealand had been missing out on conferences worth up to $90 million a year because it was impossible to run trade shows alongside them. "So you're actually losing out on not only the income you would get from running the conference and trade show here, but also the tourism spend as well." Clinicians had also been missing out. "Doctors here aren't getting exposed to all of the latest and greatest in terms of conferences, scientific exchange, the information and updates on all sorts of things." However, Auckland University associate professor of psychological medicine David Menkes said it was "misleading" to suggest doctors did not already have access to the latest information about new treatments. "But usually that information comes not from a company rep, it will come from an expert who's presenting as a colleague, rather than as an exhibitor or a sponsor of a conference." The academic psychiatrist said doctors liked to "believe they can't be swayed by corporate largesse" - but studies showed they were not immune. "That's why academic journals require peer review and disclosure of interests." Menkes is a long-time critic of New Zealand's permissive marketing regime : it is the only OECD country - apart from the United States - to allow direct-to-consumer advertising of medicines. Further loosening of the rules could compound the risk of over-prescribing, he said. "You don't want to be held up by red tape and bureaucracy, right? But you also want to have checks and balances in place. "I'm afraid this new policy doesn't have adequate checks and balances against overt promotional behaviour by vested interests." Seymour's office was unable to say when the government was planning to turn the policy into something Parliament could consider.
